Statistics on Biotechnology Use Results by sector of operation Sector Companies. Results in biotechnology for main variables and branches of activity Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.133 740 313 80 %Companies according to biotechnology used: Genetic code 32 39 16 28 %Companies according to biotechnology used: Functional units 41 44 37 27 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 27 33 13 27 %Companies according to biotechnology used: Bioprocesses 48 39 73 37 %Companies according to biotechnology used: Sub-cellular organisms 8 11 4 1 %Companies according to biotechnology used: Bio-computing 21 29 7 8 %Companies according to biotechnology used: Nanobiotechnology 14 18 9 2 %Companies according to biotechnology used: Other 13 13 11 22 Companies in which biotechnology activities are: Main and/or exclusive 564 485 70 8 Companies in which biotechnology activities are: A secondary line of business 212 129 68 15 Companies in which biotechnology activities are: A tool necessary for production 358 126 174 57 %Company by field(s) of ultimate application of biotechnology use: Human Health 50 64 28 2 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 19 19 14 35 %Company by field(s) of ultimate application of biotechnology use: Food products 29 22 48 28 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 21 19 18 54 %Company by field(s) of ultimate application of biotechnology use: Environment 13 13 13 7 %Company by field(s) of ultimate application of biotechnology use: Industry 13 15 14 1 Personnel in R&D in biotechnology (no. of persons) 10.706 7.082 2.911 713 Personnel in R&D in biotechnology (no. of persons): Researchers 6.227 4.618 1.376 234 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.479 2.464 1.536 479 Personnel in R&D in biotechnology (no. of persons): women 5.795 4.017 1.487 291 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.269 2.462 708 99 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.527 1.555 780 192 Personnel in R&D in biotechnology (FTE) 7.716,4 5.271,6 1.994,1 450,7 Personnel in R&D in biotechnology (FTE): Researchers 4.603,1 3.428,2 1.011,8 163,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.113,3 1.843,4 982,3 287,6 Personnel in R&D in biotechnology (FTE): women 4.292,9 2.988,8 1.092,6 211,6 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.446,4 1.824,2 546,4 75,8 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.846,5 1.164,5 546,2 135,8 Internal expenditure on R&D (thousands of euros) 616.053 419.246 169.526 27.280 1) By nature of the expense: Current expenses 574.245 386.169 162.807 25.269 1.1) Remuneration to researchers 221.741 154.058 59.929 7.754 1.2) Remuneration to technicians and assistants 102.464 54.152 40.900 7.411 1.3) Other current expenses 250.041 177.959 61.978 10.103 2) By nature of the expense: Capital expenses 41.808 33.077 6.719 2.012 2.1) Land and buildings 5.359 3.804 1.179 376 2.2) Equipment and instruments 29.489 22.799 5.142 1.548 2.3) Acquisition of specific R&D software 2.306 2.155 150 0 2.4) Otros productos de propiedad intelectual específicos para I+D 4.654 4.320 247 87 1) By origin of the funds: National funds 511.960 353.937 132.650 25.373 1.1) Own funds 382.335 236.135 122.657 23.543 1.2) From companies 45.024 42.403 2.620 . 1.3) Public Administration funds 72.387 63.184 7.373 1.830 1.4) From Universities 363 363 . . 1.5) From non profit private institutions 11.851 11.851 . . 1) By origin of the funds: Foreign funds 104.093 65.309 36.877 1.907 2.1) From EU programmes 21.825 20.023 1.726 77 2.2) Other foreign funds 82.269 45.287 35.151 1.831 Purchase of R&D services in biotechnology (thousands of euros) 144.342 80.058 62.756 1.527 Purchase of R&D services in biotechnology (thousands of euros): In Spain 70.458 29.338 40.495 625 Purchase of R&D services in biotechnology (thousands of euros): Abroad 73.885 50.721 22.261 902 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 48 57 31 34 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 13 12 19 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 15 16 12 20 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 12 13 12 7 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 16 18 11 9 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 16 19 11 7 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 16 17 12 12 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 36 39 33 21 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 49 54 38 38 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 18 19 15 18 % Companies that have requested biotechnology patents in Biotechnology 16 20 9 5 Number of patents requested 633 497 87 49 % Companies with income of an international origin related to biotechnological activities 24 26,6 22,3 6,7 % Turnover representing income of an international origin related to biotechnological activities 1,4 4,2 1,2 0,7 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 57,3 35,2 64,8 44,6 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 42,7 64,8 35,2 55,4 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 82,3 92 78,8 97 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 16,5 4,5 20,7 3 % Income of an international origin related with activities according to the classification: Operating source abroad 1 3,2 0,3 . % Income of an international origin related with activities according to the classification: Other 0,3 0,4 0,3 . Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute